Text mining as a solution: Find disease-related genetic variation in literature
Genetic causes and associations of disease remain important areas of research so that our society can better prevent and treat diseases.
Finding such genetic variation information within published literature remains a challenge due to the large volume and heterogeneity of articles, and the intense rate of publication in these fields.
In this webinar we will cover:
- How to find the context, not just the word
- some use cases for text mining genetic variation data
- show how we have developed a solution that enables researchers to quickly find genetic variations in the literature
- Explore how you can leverage a semantic search solution to identify disease-related genetic variation information to address your research needs.
Join George Jiang, Product Manager, Elsevier Text Mining solution and learn how to build your own solution with our text mining solution for searching for various genetic variation types.
Italy customer engagement and learning
Presenter: Agne Karose
Date: Feb-15-2021
Solutions: Digital Commons; Funding Institutional; Mendeley Data platform; Pure; Research Intelligence; SciVal; Scopus
Themes: Analytics and big data; Collaboration tools; Data management & migration; Funding; Information management; Insitutional repository; Open science and open access; Research; Research data management; Research metrics; Researcher strategy; Showcase; Stay up to date
Italy customer engagement and learning program
Property searching in Reaxys and related chemistry databases
Presenter: Lisette van Kessel
Date: Dec-10-2020
Solutions: Reaxys; Research Intelligence
Themes: Chemistry; Discoverability; Research; Stay up to date; Universities
How do we find reliable spectroscopic, physico-chemical or biochemical properties of chemical substances quickly? Prof. Damon Ridley will walk us through the exciting wor
Model-based strategy to clinical doses for ADC
Presenter: Julie Desrivot Quenelle, Eric Didier
Date: Oct-27-2020
Solutions: Life Sciences
Themes: Life sciences
The PK/PD scientists has developed the modelling and simulation-based tools to guide the choice of most safe and efficacious dosing regimen of antibody drug conjugate.